Lactate does not activate NF-κB in oxidative tumor cells Front Pharmacol 2015; http://dx.doi.org/10.3389/fphar.2015.00228 Van Hée VF, Pérez-Escuredo J, Cacace A, Copetti T, Sonveaux P
Sulfonamide bearing pyrazolylpyrazolines as potent inhibitors of carbonic anhydrase isoforms I, II, IX and XII Bioorg Med Chem Lett. 2015 In pressKhloya P, Ceruso M, Ram S, Supuran CT, Sharma PK.
The glutamate transport inhibitor DL-Threo-β-Benzyloxyaspartic acid (DL-TBOA) differentially affects SN38- and oxaliplatin-induced death of drug-resistant colorectal cancer cells BMC Cancer. 2015;15:411.Pedraz-Cuesta E, Christensen S, Jensen AA, Jensen NF, Bunch L, Romer MU, Brünner N, Stenvang J, Pedersen SF
Metabolism and its sequelae in cancer evolution and therapy Cancer J. 2015;21:88-96Gillies RJ, Gatenby RA.
Common responses of tumors and wounds to hypoxia Cancer J. 2015;21:75-87Payen VL, Brisson L, Dewhirst MW, Sonveaux P
NADH-linked metabolic plasticity of MCF-7 breast cancer cells surviving in a nutrient-deprived microenvironment J Cell Biochem 2015, in pressOtto A, Hintermair J, Janzon C
Glycolysis, tumor metabolism, cancer growth and dissemination. A new pH-based etiopathogenic perspective and therapeutic approach to an old cancer question Oncoscience 2014; 1:777-802Khalid O. Alfarouk, Daniel Verduzco, Cyril Rauch, Abdel Khalig Muddathir, Adil H. H. Bashir, Gamal O. Elhassan, Muntaser E. Ibrahim, Julian David Polo Orozco, Rosa Angela Cardone, Stephan J. Reshkin and Salvador Harguindey
Impairment of Lysosomal Activity as a Therapeutic Modality Targeting Cancer Stem Cells of Embryonal Rhabdomyosarcoma Cell Line RD. PLoS One. 2014 Oct 20;9:e110340.Salerno M, Avnet S, Bonuccelli G, Hosogi S, Granchi D, Baldini N.